Synthesis of novel 2, 5-dihydrofuran derivatives and evaluation of their anticancer activity

European Journal of Medicinal Chemistry
2012.0

Abstract

According to metal-catalyzed [3 + 2] cycloaddition reaction, we synthesized a series of novel 2, 5-dihydrofuran derivatives and evaluated their in vitro anti-cancer activities via MTT method. The bioassay showed that the majority of the resultant compounds exerted anti-tumor effect against four human cancer cell lines to various extents, which supported the rationale of the design. Compounds 9e and 10g showed the highest activity with broad anti-cancer spectrum, which were good candidates for further evaluation.

Knowledge Graph

Similar Paper

Synthesis of novel 2, 5-dihydrofuran derivatives and evaluation of their anticancer activity
European Journal of Medicinal Chemistry 2012.0
Synthesis and antitumor evaluation of 2,3-diarylbenzofuran derivatives on HeLa cells
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis of some (E)-6-[2-(furan-2-yl)ethenyl]-1,2,4-triazin-5-ones and their biological evaluation as antitumor agents
Medicinal Chemistry Research 2013.0
Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents
European Journal of Medicinal Chemistry 2012.0
Synthesis and antitumor activity of 2,5-bis(3′-indolyl)-furans and 3,5-bis(3′-indolyl)-isoxazoles, nortopsentin analogues
Bioorganic & Medicinal Chemistry 2010.0
Design and synthesis of novel 2′-hydroxy group substituted 2-pyridone derivatives as anticancer agents
European Journal of Medicinal Chemistry 2013.0
Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents
European Journal of Medicinal Chemistry 2011.0
Synthesis and biological evaluation of novel 4,7-dihydroxycoumarin derivatives as anticancer agents
Bioorganic & Medicinal Chemistry Letters 2019.0
Synthesis of 1-(3′,4′,5′-trimethoxy) phenyl naphtho[2,1b]furan as a novel anticancer agent
Bioorganic & Medicinal Chemistry Letters 2006.0
Design, synthesis and anticancer activity of N-(1-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl derivatives
Bioorganic & Medicinal Chemistry Letters 2017.0